Drug Target Review2023-08-30T10:00:18
St. Jude Children’s Research Hospital, in collaboration with ESR Limited, discovered that specific immune cells present in individuals months before a flu infection can better predict symptom development compared to current antibody-based methods.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-07-04T10:05:58
Sponsored by Revvity
2023-10-06T10:52:00
Contributor Dr David Lonard
2023-04-04T15:03:09
Sponsored by Agilent
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
Site powered by Webvision Cloud